Dr Andrew Leach
Dr Andrew Leach
ABOUT
Dr Andrew Leach is a Senior Lecturer at the University of Manchester. His expertise is in computational chemistry particularly applied to mechanism and medicinal chemistry. He is an inventor of capivasertib (currently in Phase III clinical trials for breast and prostate cancer) and a director and co-founder of Medchemica limited that provides software and services to the pharmaceutical industry. His current research is supported by EPSRC, NC3Rs and Wellcome Trust. He is the social responsibility lead for the Division of Pharmacy and Optometry and first year tutor for the MPharm degree. He is an enthusiastic member of Sale Brass Band.
